Prevalence of Antimicrobial Resistance in Klebsiella pneumoniae in the South African Populations: A Systematic Review and Meta-Analysis of Surveillance Studies
Abstract
Antimicrobial resistance (AMR) poses a critical global health threat, with Klebsiella pneumoniae emerging as a high-priority pathogen due to escalating resistance rates. This systematic review and meta-analysis evaluated the AMR profiles of K. pneumoniae isolates from South Africa, a resource-limited setting where AMR burdens remain understudied. A comprehensive search of PubMed, Web of Science, and Google Scholar (January 2000 to June 2024) identified studies reporting resistance data. Nineteen studies comprising 9402 isolates were included, and data were analyzed using random-effects models. Pooled resistance prevalence was highest for amoxicillin (69.3%; 95% CI: 64.1%-74.1%), followed by second-generation cephalosporins (70.9%; 95% CI: 65.3%-75.8%), trimethoprim-sulfamethoxazole (57.8%; 95% CI: 52.4%-63.0%), and carbapenems, with imipenem resistance at 33.2% (95% CI: 28.5%-38.3%). Significant heterogeneity was observed (I² > 90%, p < 0.001), likely due to differences in study populations such as clinical versus environmental isolates, and regional prescribing practices. Publication bias was detected (Egger's test: p = 1.45 × 10⁻¹⁴), indicating possible underreporting of small-scale studies with null findings. These findings highlight alarming resistance rates to first-line antibiotics in South Africa and underscore the urgent need for multisectoral interventions. Priority actions should include standardized AMR surveillance to harmonize data collection, expanded…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.